Simon Thezenas
Campus Val D'Aurelle 208 Avenue Des Apothicaires, Montpellier Cedex 5
Montpellier, 34298, France
Montpellier, 34298, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
An exploratory study of circulating cell-free mRNAs across colorectal cancer stages.
Journal: iScience
Published: January 13, 2026
Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort Studies.
Journal: Clinical breast cancer
Published: December 29, 2025
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 13, 2025
Exploring the spectrum of HER2 in non-metastatic triple negative breast cancer: from HER2-Null to HER2-low, including HER2-ultralow status.
Journal: Virchows Archiv : an international journal of pathology
Published: July 21, 2025
The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer.
Journal: The oncologist
Published: June 23, 2025
Evaluation of physical rehabilitation in patients receiving curative treatment for head and neck cancer: The NUTRIMOUV randomized phase II trial.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 21, 2025
Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features.
Journal: Frontiers in immunology
Published: October 07, 2024
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors.
Journal: Journal of neuro-oncology
Published: September 27, 2024
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging Biomarkers.
Journal: Cancer medicine
Published: August 07, 2024
Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research.
Journal: International journal of environmental research and public health
Published: November 15, 2023
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: September 26, 2023
Last Updated: 09/26/2026